A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Public ClinicalTrials.gov record NCT01136655. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Blinded, 5-period Cross-over, Placebo and Active Controlled, Multicenter, Dose-finding Study Comparing Single Doses of Formoterol 2.25 µg, 4.5 µg, and 9 µg Delivered Via Symbicort pMDI and Foradil® 12 µg Evaluating the Relative Bronchodilating Effects and Safety in Children
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This purpose of the study is to investigate the bronchodilating effects of 3 different dosages of formoterol given in combination with budesonide as Symbicort pMDI.
Study identification
- NCT ID
- NCT01136655
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- 80/2.25 μg Symbicort pMDI Drug
- 80/4.5 μg Symbicort pMDI Drug
- Foradil Aerolizer 12 μg Drug
- 40 μg budesonide HFA pMDI Drug
- placebo HFA pMDI Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- Oct 31, 2013
2010 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 9
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntington | California | — | — |
| Research Site | Long Beach | California | — | — |
| Research Site | Mission Viejo | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | Rolling Hills Estate | California | — | — |
| Research Site | Sarasota | Florida | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Morrisville | North Carolina | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Eugene | Oregon | — | — |
| Research Site | Lake Oswego | Oregon | — | — |
| Research Site | Medford | Oregon | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Altoona | Pennsylvania | — | — |
| Research Site | Upland | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | El Paso | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Waco | Texas | — | — |
| Research Site | Springfield | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01136655, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 31, 2013 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01136655 live on ClinicalTrials.gov.